| Shares
| Value
|
Preferred Stocks - 6.0%
|
Communication Services - 1.8%
|
Specialty Retail - 1.8%
|
Evolve Vacation Rental Network, Inc. Series 8
Acquisition Date: 6/15/18,
Cost $3,999,9991,3,4
| 470,013
| $9,329,758
|
Total Communication Services
|
| 9,329,758
|
Health Care - 1.8%
|
Biotechnology - 0.8%
|
Centrexion Therapeutics Corp.
Acquisition Date: 12/18/17,
Cost $2,995,0071,3,4
| 1,663,893
| 166,389
|
DNA Script Series C
Acquisition Date: 10/8/21,
Cost $3,431,7211,3,4
| 3,955
| 1,471,260
|
YAP Therapeutics, Inc. Series B
Acquisition Date: 1/12/22,
Cost $3,000,0051,3,4
| 64,544
| 3,004,523
|
|
| 4,642,172
|
Health Care Equipment & Supplies - 0.8%
|
Adagio Medical, Inc. Series E
Acquisition Date: 11/9/20,
Cost $4,000,0031,3,4
| 176,913
| 260,062
|
Beta Bionics, Inc. Series B
Acquisition Date: 10/9/18,
Cost $3,999,9761,3,4
| 266,310
| 2,290,266
|
Beta Bionics, Inc. Series C
Acquisition Date: 2/16/22,
Cost $959,987 1,3,4
| 86,280
| 698,868
|
Beta Bionics, Inc. Series D
Acquisition Date: 8/28/23,
Cost $706,8711,3,4
| 119,047
| 870,234
|
|
| 4,119,430
|
Health Care Providers & Services - 0.2%
|
Binx Health, Inc. Series E
Acquisition Date: 5/26/21,
Cost $6,500,0411,3,4
| 24,179
| 1,064,360
|
Total Health Care
|
| 9,825,962
|
Information Technology - 1.4%
|
IT Services - 0.8%
|
Skyryse, Inc. Series B
Acquisition Date: 10/21/21,
Cost $4,184,9831,3,4
| 169,570
| 4,184,987
|